Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 46.73% vs 80.65% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 43.25% vs 108.32% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 17.16% vs -5.48% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is 35.53% vs 112.47% in Mar 2025
Compare Profit and Loss Results of Anlon Healthcare
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
176.00
599.00
-423.00
-70.62%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
176.00
599.00
-423.00
-70.62%
Expenditure (Ex Depriciation)
Stock Adjustments
-16.00
1.00
-17.00
-1,700.00%
Raw Materials Consumed
129.00
292.00
-163.00
-55.82%
Power & Fuel Cost
3.00
24.00
-21.00
-87.50%
Employee Cost
5.00
104.00
-99.00
-95.19%
Operating Expenses
3.00
12.00
-9.00
-75.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
33.00
-33.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
2.00
21.00
-19.00
-90.48%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
130.00
523.00
-393.00
-75.14%
Operating Profit (PBDIT) excl Other Income
46.00
76.00
-30.00
-39.47%
Other Income
0.00
3.00
-3.00
-100.00%
Operating Profit (PBDIT)
46.00
79.00
-33.00
-41.77%
Interest
4.00
36.00
-32.00
-88.89%
Profit before Depriciation and Tax
42.00
42.00
0.00
0.00%
Depreciation
1.00
13.00
-12.00
-92.31%
Profit Before Taxation & Exceptional Items
40.00
29.00
11.00
37.93%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
40.00
29.00
11.00
37.93%
Provision for Tax
12.00
0.00
12.00
0%
Profit After Tax
27.00
30.00
-3.00
-10.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
23.00
-138.00
161.00
116.67%
Profit Available for appropriations
50.00
-107.00
157.00
146.73%
Appropriations
50.00
-107.00
157.00
146.73%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
5.84
9.32
-3.48
-37.34%
Profit And Loss - Net Sales
Net Sales 176.50 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 46.73% vs 80.65% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 46.14 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 43.25% vs 108.32% in Mar 2025
Profit And Loss - Interest
Interest 4.35 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 17.16% vs -5.48% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 27.81 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 35.53% vs 112.47% in Mar 2025






